{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:06Z","timestamp":1791839946953,"version":"4.3.4"},"reference-count":79,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The peptide P10 is a vaccine candidate for Paracoccidioidomycosis, a systemic mycosis caused by fungal species of the genus Paracoccidioides spp. We have previously shown that peptide P10 vaccination, in the presence of several different adjuvants, induced a protective cellular immune response mediated by CD4+ Th1 lymphocytes that was associated with the increased production of IFN-\u03b3 in mice challenged with a virulent isolate of Paracoccidoides brasiliensis. Cationic liposomes formulated with dioctadecyldimethylammonium and trehalose dibehenate (DDA\/TDB, termed also CAF01\u2013cationic adjuvant formulation) have been developed for safe administration in humans and CAF01 liposomes are utilized as an adjuvant for modulating a robust Th1\/Th17 cellular response. We evaluated the efficacy of the adsorption of peptide P10 to CAF01 cationic liposomes and used the generated liposomes to vaccinate C57Bl\/6 mice infected with P. brasiliensis. Our results showed that P10 was efficiently adsorbed onto CAF01 liposomes. The vaccination of infected mice with cationic liposomes formulated with DDA\/TDB 250\/50 \u00b5g\/mL and 20 \u00b5g of P10 induced an effective cellular immune response with increased levels of Th17 cytokines, which correlated with significant decreases in the fungal burdens in lungs and protective granulomatous tissue responses. Hence, cationic liposomes of DDA\/TDB 250\/50 \u00b5g\/mL with 20 \u00b5g of P10 are a promising therapeutic for safely and effectively improving the treatment of paracoccidioidomycosis.<\/jats:p>","DOI":"10.3390\/jof6040347","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T09:17:04Z","timestamp":1607419024000},"page":"347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-3225","authenticated-orcid":false,"given":"Marcelo Valdemir de","family":"Ara\u00fajo","sequence":"first","affiliation":[{"name":"Departamento de Microbiologia, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-3538","authenticated-orcid":false,"given":"Samuel Rodrigues Dos","family":"Santos J\u00fanior","sequence":"additional","affiliation":[{"name":"Departamento de Microbiologia, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-5754","authenticated-orcid":false,"given":"Joshua D.","family":"Nosanchuk","sequence":"additional","affiliation":[{"name":"Departments of Medicine (Division of Infectious Disease), Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-9809","authenticated-orcid":false,"given":"Carlos Pelleschi","family":"Taborda","sequence":"additional","affiliation":[{"name":"Departamento de Microbiologia, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"},{"name":"Departamento de Dermatologia, Instituto de Medicina Tropical de S\u00e3o Paulo\u2014LIM53, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 4023-062, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Souza, A.C.O., and Taborda, C.P. (2020). Epidemiology of Dimorphic Fungi. Reference Module in Life Sciences, Elsevier BV.","DOI":"10.1016\/B978-0-12-809633-8.12056-4"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1590\/0037-8682-0230-2017","article-title":"Brazilian guidelines for the clinical management of paracoccidioidomycosis","volume":"50","author":"Mendes","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fgb.2017.05.007","article-title":"Species boundaries in the human pathogen Paracoccidioides","volume":"106","author":"Turissini","year":"2017","journal-title":"Fungal Genet. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13693786.2013.794311","article-title":"Paracoccidioides lutziisp. nov.: Biological and clinical implications","volume":"52","author":"Teixeira","year":"2013","journal-title":"Med. Mycol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/molbev\/msj008","article-title":"Cryptic Speciation and Recombination in the Fungus Paracoccidioides brasiliensis as Revealed by Gene Genealogies","volume":"23","author":"Matute","year":"2006","journal-title":"Mol. Biol. Evol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ympev.2009.04.005","article-title":"Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus","volume":"52","author":"Teixeira","year":"2009","journal-title":"Mol. Phylogenet. Evol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/EC.05052-11","article-title":"Molecular and Morphological Data Support the Existence of a Sexual Cycle in Species of the Genus Paracoccidioides","volume":"12","author":"Teixeira","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Theodoro, R.C., Teixeira, M.D.M., Felipe, M.S.S., Paduan, K.D.S., Ribolla, P.M., San-Blas, G., and Bagagli, E. (2012). Genus Paracoccidioides: Species Recognition and Biogeographic Aspects. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037694"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/377538","article-title":"Residual Pulmonary Abnormalities in Adult Patients with Chronic Paracoccidioidomycosis: Prolonged Follow-Up after Itraconazole Therapy","volume":"37","author":"Tobon","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2017.00224","article-title":"Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses as Vaccine Candidates","volume":"8","author":"Travassos","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s40475-019-00179-w","article-title":"Vaccine Development to Systemic Mycoses by Thermally Dimorphic Fungi","volume":"6","author":"Rossi","year":"2019","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/IAI.66.2.786-793.1998","article-title":"Mapping of the T-Cell Epitope in the Major 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensisWhich Induces a Th-1 Response Protective against Fungal Infection in BALB\/c Mice","volume":"66","author":"Taborda","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0003-9861(91)90475-X","article-title":"The 43-kDa glycoprotein from the human pathogen Paracoccidioides brasiliensis and its deglycosylated form: Excretion and susceptibility to proteolysis","volume":"289","author":"Puccia","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JCM.41.8.3675-3680.2003","article-title":"Detection of Circulating gp43 Antigen in Serum, Cerebrospinal Fluid, and Bronchoalveolar Lavage Fluid of Patients with Paracoccidioidomycosis","volume":"41","author":"Colombo","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/jcm.26.10.2147-2151.1988","article-title":"Production of Paracoccidioides brasiliensis exoantigens for immunodiffusion tests","volume":"26","author":"Unterkircher","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jr, N.P.L., Vallejo, M.C., Concei\u00e7\u00e3o, P.M., Camargo, Z.P., Hahn, R., and Puccia, R. (2014). Paracoccidioides lutzii Plp43 Is an Active Glucanase with Partial Antigenic Identity with P. brasiliensis gp43. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003111"},{"key":"ref_17","first-page":"154","article-title":"The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide","volume":"3","author":"Emayorga","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide Vaccine: Progress and Challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pharmaceutics5030392","article-title":"Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators","volume":"5","author":"Elsharkawy","year":"2013","journal-title":"Pharmaceutics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2017.00336","article-title":"Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity","volume":"8","author":"Souza","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/erv.11.17","article-title":"Cationic liposomes as vaccine adjuvants","volume":"10","author":"Christensen","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2353\/ajpath.2006.050848","article-title":"Trehalose 6,6\u2032-Dimycolate and Lipid in the Pathogenesis of Caseating Granulomas of Tuberculosis in Mice","volume":"168","author":"Hunter","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_23","first-page":"371","article-title":"Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease","volume":"36","author":"Hunter","year":"2006","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tube.2005.08.017","article-title":"The role of trehalose dimycolate (cord factor) on morphology of virulent M. tuberculosis in vitro","volume":"86","author":"Hunter","year":"2006","journal-title":"Tuberculosis"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Christensen, D. (2017). Development and Evaluation of CAF01. Immunopotentiators in Modern Vaccines, Elsevier BV.","DOI":"10.1016\/B978-0-12-804019-5.00017-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.05.019","article-title":"The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production","volume":"154","author":"Devitt","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0264-410X(89)90242-9","article-title":"Lethal toxicity and adjuvant activities of synthetic TDM and its related compounds in mice","volume":"7","author":"Sakurai","year":"1989","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Desel, C., Werninghaus, K., Ritter, M., Jozefowski, K., Wenzel, J., Russkamp, N., Schleicher, U., Christensen, D., Wirtz, S., and Kirschning, C. (2013). The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053531"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2010.11.021","article-title":"Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method","volume":"150","author":"Nordly","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20081445","article-title":"Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcR\u03b3\u2013Syk\u2013Card9\u2013dependent innate immune activation","volume":"206","author":"Werninghaus","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","article-title":"Immunocorrelates of CAF family adjuvants","volume":"39","author":"Pedersen","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"Joosten","year":"2014","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2009.07.066","article-title":"Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo","volume":"27","author":"Lincopan","year":"2009","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0009-3084(00)00127-4","article-title":"Phase transition in dioctadecyldimethylammonium bromide and chloride vesicles prepared by different methods","volume":"105","author":"Feitosa","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6\u2032-dibehenate)\u2014A novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jphp.12173","article-title":"Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants","volume":"66","author":"Hussain","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/21691401.2018.1438450","article-title":"Cationic DDA\/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity","volume":"46","author":"Qu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/02681218980000111","article-title":"Evaluation of the pathogenicity and immunogenicity of seven Paracoccidioides brasiliensis isolates in susceptible inbred mice","volume":"27","author":"Burger","year":"1989","journal-title":"J. Med. Veter. Mycol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11046-014-9801-1","article-title":"Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB\/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis","volume":"178","author":"Luft","year":"2014","journal-title":"Mycopathologia"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Danaei, M., Dehghankhold, M., Ataei, S., Davarani, F.H., Javanmard, R., Dokhani, A., Khorasani, S., and Mozafari, M. (2018). Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"054107","DOI":"10.1063\/1.4962992","article-title":"Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry","volume":"10","author":"Clayton","year":"2016","journal-title":"Biomicrofluidics"},{"key":"ref_43","first-page":"83","article-title":"Formulation and in vitro evaluation of flufenamic acid loaded deformable liposomes for improved skin delivery","volume":"9","author":"Badran","year":"2014","journal-title":"Dig. J. Nanomater. Biostructures"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2011.02.006","article-title":"Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application","volume":"408","author":"Chen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.24071\/jpsc.142728","article-title":"Optimization of mixing temperature and sonication duration in liposome preparation","volume":"14","author":"Putri","year":"2017","journal-title":"J. Pharm. Sci. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/AAC.00220-06","article-title":"Peptide Immunization as an Adjuvant to Chemotherapy in Mice Challenged Intratracheally with Virulent Yeast Cells of Paracoccidioides brasiliensis","volume":"50","author":"Marques","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Abeyratne, E., Tharmarajah, K., Freitas, J.R., Mostafavi, H., Mahalingam, S., Zaid, A., Zaman, M., and Taylor, A. (2020). Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00304"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1016\/j.vaccine.2011.06.040","article-title":"Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes","volume":"29","author":"Rosenkrands","year":"2011","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-020-0157-x","article-title":"Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge","volume":"5","author":"Nguyen","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Riccomi, A., Piccaro, G., Christensen, D., Palma, C., Andersen, P., and Vendetti, S. (2019). Parenteral Vaccination with a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00934"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41385-019-0145-5","article-title":"Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection","volume":"12","author":"Woodworth","year":"2019","journal-title":"Mucosal Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciy1087","article-title":"Controlled Human Malaria Infection of Healthy Adults with Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2","volume":"69","author":"Lalremruata","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mortensen, R., Christensen, D., Hansen, L.B., Christensen, J.P., Andersen, P., and Dietrich, J. (2017). Local Th17\/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175707"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1586\/14787210.6.2.251","article-title":"Treatment options for paracoccidioidomycosis and new strategies investigated","volume":"6","author":"Travassos","year":"2008","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.161.8.4000","article-title":"Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen","volume":"161","author":"Brewer","year":"1998","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"Mann","year":"2009","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: Role of physicochemical properties of particulate carriers\u2014liposomes and microspheres\u2014on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J. Control. Release"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0005-2736(91)90268-D","article-title":"Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size","volume":"1061","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.2147\/IJN.S87120","article-title":"Influence of cationic lipid concentration on properties of lipid\u2013polymer hybrid nanospheres for gene delivery","volume":"10","author":"Park","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11095-012-0856-8","article-title":"Protein Antigen Adsorption to the DDA\/TDB Liposomal Adjuvant: Effect on Protein Structure, Stability, and Liposome Physicochemical Characteristics","volume":"30","author":"Hamborg","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.bbamem.2014.04.013","article-title":"Elucidating the mechanisms of protein antigen adsorption to the CAF\/NAF liposomal vaccine adjuvant systems: Effect of charge, fluidity and antigen-to-lipid ratio","volume":"1838","author":"Hamborg","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Schmidt, S.T., Foged, C., Korsholm, K.S., Rades, T., and Christensen, D. (2016). Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Pharmaceutics, 8.","DOI":"10.3390\/pharmaceutics8010007"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.4049\/jimmunol.0803282","article-title":"Lipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection","volume":"182","author":"Chan","year":"2009","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/IAI.01389-13","article-title":"Interleukin-17-Induced Protein Lipocalin 2 Is Dispensable for Immunity to Oral Candidiasis","volume":"82","author":"Ferreira","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S38707","DOI":"10.4137\/III.S38707","article-title":"Immunity against Fungal Infections","volume":"8","author":"Jiang","year":"2016","journal-title":"Immunol. Immunogenet. Insights"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 Cells in Immunity to Candida albicans","volume":"11","author":"Gaffen","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.4049\/jimmunol.1301679","article-title":"Selective Ablation of Lung Epithelial IKK2 Impairs Pulmonary Th17 Responses and Delays the Clearance ofPneumocystis","volume":"191","author":"Pasparakis","year":"2013","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice","volume":"121","author":"Gern","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00018-012-1163-6","article-title":"Diversity of IL-17-producing T lymphocytes","volume":"70","author":"Kim","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp 130 and the interleukin-6 family of cytokines","volume":"15","author":"Taga","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors ROR\u03b1 and ROR & gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-7104-6_9","article-title":"Peptide Vaccine Against Paracoccidioidomycosis","volume":"Volume 1625","author":"Taborda","year":"2017","journal-title":"Methods in Molecular Biology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.1300283","article-title":"Protective CD4 T Cells Targeting Cryptic Epitopes of Mycobacterium tuberculosis Resist Infection-Driven Terminal Differentiation","volume":"192","author":"Woodworth","year":"2014","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3389\/fimmu.2017.00949","article-title":"Th17-Inducing Cytokines IL-6 and IL-23 Are Crucial for Granuloma Formation during Experimental Paracoccidioidomycosis","volume":"8","author":"Rocha","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2013.00120","article-title":"The Role of the Innate Immune System in Granulomatous Disorders","volume":"4","author":"Petersen","year":"2013","journal-title":"Front. Immunol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/4\/347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:14Z","timestamp":1760179334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/4\/347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jof6040347"],"URL":"https:\/\/doi.org\/10.3390\/jof6040347","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]}}}